Recombinant Human Anti-C11H8O2 Soluble TCR (A-F7) (C-Cys) (CAT#: VS-0622-YF4161)
Human TCR (A-F7) recognizes C11H8O2 peptide (2-hydroxy-1-naphthaldehyde) in the context of human MR1. Soluble TCR is expressed with C-terminal Cys strategy (TRAV-TRAC partial-Cys, TRBV-TRBC partial-Cys). Depending the C-terminal Cys, two chains form heterodimer. Please note that the activity is not guaranteed.
Specific Inquiry Online Inquiry
Specifications
- Host Species
- Human
- Target
- C11H8O2
- Epitope
- 2-hydroxy-1-naphthaldehyde
- MHC
- human MR1
- Clone
- A-F7
- Type
- Soluble TCR (C-Cys)
- TCR Expression Strategy
- C-Cys strategy: the alpha and beta chain (without transmembrane and cytosolic region) can form heterodimer based on C-terminal Cys. The soluble TCR contains variable regions and partial constant regions.
Target
- Alternative Names
- 2-OH-1-NA; 2-hydroxy-1-naphthaldehyde
Downloads
Download resources about recombinant antibody development and antibody engineering to boost your research.
See other products for "Clone A-F7"
There are currently no Customer reviews or questions for VS-0622-YF4161. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
Send Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
